Mostrar el registro sencillo del ítem

dc.contributor.author
Moyano, Agustina Ayelén  
dc.contributor.author
Ferressini, N.  
dc.contributor.author
de Matteo, Elena Noemí  
dc.contributor.author
Preciado, Maria Victoria  
dc.contributor.author
Chabay, Paola Andrea  
dc.date.available
2023-06-12T14:24:24Z  
dc.date.issued
2019  
dc.identifier.citation
Characterization of macrophage innate immune response at the site of Epsein Barr Virus (EBV) entry in pediatric patients; International Centre for Genetic Engineering and Biotechnology DNA Tumour Virus Meeting; Trieste; Italia; 2019; 1-1  
dc.identifier.uri
http://hdl.handle.net/11336/200277  
dc.description.abstract
Macrophage?s role in the management of Epstein Barr virus (EBV) infection is unexplored. Therefore, our aim is to characterize macrophages in tonsil microenvironment in pediatric patients infected with EBV. Methods: We studied 72 patients with tonsil surgery. The infection status was studied by Anti-EBV VCA-IgM, VCA-IgG, EA-IgG and -EBNA1 IgG, to define primary infection (PI), healthy carrier (HC), reactivation (R) and no infected (NI). Viral load and typification was assessed by PCR. Latency pattern was evaluated by Immunohistochemistry (IHC) for LMP1, EBNA2 and BMRF1, and EBERS in Situ Hybridization (ISH). Macrophages characterization was performed by CD68, CD163, and CD169 IHC,in germinal center (GC) and interfollicular (IF) regions and results were expressed as positive cells/mm2.Results:Of our patients, 38 wereHC, 20 PI, 10 had viral Rand 4 were NI. 41.5% of patients expressed Latency I, 31.7% Latency II, 12.2% Latency III and 14.6% Latency 0, while 14.6% also showed positive cells for lyticantigens. We defined the macrophage´spolarization profile M1as CD68/CD163 >1.5, and M2 as CD163/CD68 >1.5;M1 profile was observed in 89% of the patients. CD68+ cell counts was statically higher compared to CD163+ and CD169+ in the entire series and within groups (ANOVA p<0.05). Both CD68and CD163 cell counts were statistically higher in the IF region in the whole series and in the 3 subgroups (PI, P and R)(p<0.05 T test), whereas CD169+ cells were statistically increased at theGC in the entire cohort, and in HC subgroup (p<0.05 T test). When latency patterns were clustered into 0-I and II-III, only a mayor recruitment of CD163+ cells in patients expressing Latency II-III was observed (Unpaired T test p=0.01). No correlation between viral load and CD68, CD163 or CD169 were demonstrated (p<0.05 Spearman)and no significant differences were evidenced these markers between EBV1 or EBV2 types (p>0.05, unpaired T test). Conclusions: This is the first work that characterize the macrophages involvement at the site of viral entrance. The prevalence of CD68 over CD163 shows a predominance of M1 profile, with antimicrobial and inflammatoryactivity, regardless of the infection status. These results are in line with previous observations in our laboratory, in which M1 prevails in the microenvironment of EBV- associated Hodgkin Lymphomas (HL). Therefore, M1 polarization pattern is prevalent in the context of EBV infection, despite the lymphomagenesis process.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
International Centre for Genetic Engineering and Biotechnology  
dc.rights
info:eu-repo/semantics/restrictedAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Epstein Barr virus  
dc.subject
macrophage  
dc.subject
polarization  
dc.subject
tonsils  
dc.subject.classification
Patología  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Characterization of macrophage innate immune response at the site of Epsein Barr Virus (EBV) entry in pediatric patients  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.type
info:eu-repo/semantics/conferenceObject  
dc.type
info:ar-repo/semantics/documento de conferencia  
dc.date.updated
2022-11-25T00:21:29Z  
dc.journal.pagination
1-1  
dc.journal.pais
Italia  
dc.journal.ciudad
Trieste  
dc.description.fil
Fil: Moyano, Agustina Ayelén. Gobierno de la Ciudad de Buenos Aires. Instituto Multidisciplinario de Investigaciones en Patologías Pediátricas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto Multidisciplinario de Investigaciones en Patologías Pediátricas; Argentina  
dc.description.fil
Fil: Ferressini, N.. No especifíca;  
dc.description.fil
Fil: de Matteo, Elena Noemí. Gobierno de la Ciudad de Buenos Aires. Instituto Multidisciplinario de Investigaciones en Patologías Pediátricas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto Multidisciplinario de Investigaciones en Patologías Pediátricas; Argentina  
dc.description.fil
Fil: Preciado, Maria Victoria. Gobierno de la Ciudad de Buenos Aires. Instituto Multidisciplinario de Investigaciones en Patologías Pediátricas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto Multidisciplinario de Investigaciones en Patologías Pediátricas; Argentina  
dc.description.fil
Fil: Chabay, Paola Andrea. Gobierno de la Ciudad de Buenos Aires. Instituto Multidisciplinario de Investigaciones en Patologías Pediátricas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto Multidisciplinario de Investigaciones en Patologías Pediátricas; Argentina  
dc.conicet.rol
Autor  
dc.conicet.rol
Autor  
dc.conicet.rol
Autor  
dc.conicet.rol
Autor  
dc.conicet.rol
Autor  
dc.conicet.rol
Autor  
dc.conicet.rol
Autor  
dc.conicet.rol
Autor  
dc.coverage
Internacional  
dc.type.subtype
Reunión  
dc.description.nombreEvento
International Centre for Genetic Engineering and Biotechnology DNA Tumour Virus Meeting  
dc.date.evento
2019-07-09  
dc.description.ciudadEvento
Trieste  
dc.description.paisEvento
Italia  
dc.type.publicacion
Book  
dc.description.institucionOrganizadora
International Centre for Genetic Engineering and Biotechnology  
dc.source.libro
International Centre for Genetic Engineering and Biotechnology DNA Tumour Virus Meeting  
dc.date.eventoHasta
2019-07-14  
dc.type
Reunión